On Demand Webinars
-
Your AKTA Oligosynt™ System : It's More Than A Machine
2/9/2026
Discover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.
-
The mRNA Journey: From Design To LNP-Ready Molecules For Research
11/25/2025
Learn a validated, end-to-end protocol for producing high-quality in vitro transcription (IVT) mRNA for preclinical research. Find out how to optimize sequence design, small-scale synthesis, and more.
-
Training Biomanufacturing Operators Faster And More Effectively
7/24/2024
Could a new approach to operator training help minimize batch loss? Learn how blended learning can enhance training effectiveness and engagement, reducing human error in your production line.
-
Manufacturing Made More Robust And Customer-Centric
12/11/2025
Discover how regional manufacturing, risk-aware practices, and agile strategies are reshaping supply chains to deliver resilience, transparency, and sustainability in today’s complex global environment.
-
Democratizing RNA Nanotherapeutics
4/14/2022
This webinar is presented by Dr. John P. Cooke, Chair of the Department of Cardiovascular Sciences at the Houston Methodist Research Institute, Director of the Center for Cardiovascular Regeneration, and Medical Director of the RNA Therapeutics Program in the Houston Methodist DeBakey Heart and Vascular Center.
-
Are You Keeping Pace With Oligo Synthesis Optimization?
11/18/2025
The rapidly expanding oligo market demands optimized RNA synthesis. Examine key innovations and workflow insights to maximize resources and control long-term manufacturing costs.
-
Enhancing Gene Editing Outcomes And Safety for Clinical Translation With Next Generation Vectors
5/6/2026
Learn how streamlined vector backbones can improve efficiency, consistency, and expression durability when reliability matters most.
-
Scope 3 Emissions: Cut The Complexity With Creative Collaboration
11/20/2024
Delve into the crucial role of Scope 3 emissions in the biopharma industry's sustainability journey, and learn more about the challenges and opportunities of managing these types of emissions.
-
Engaging Early In Process Development To Bring mRNA Sequences To Life
Examine why template sequence characteristics are relevant for cGMP manufacturing of high-quality mRNA and consider insights on how to develop a scalable, robust, and economically viable process.
-
Can A Small Plasmid Produce Huge Benefits? The Power Of Small
1/17/2023
With benefits across applications, nanoplasmids are designed to replace antiquated bacterial backbones, while eliminating antibiotic markers that can cause regulatory concerns.